Bleeding and Platelet Disorders

Gene: MED12

Green List (high evidence)

MED12 (mediator complex subunit 12)
EnsemblGeneIds (GRCh38): ENSG00000184634
EnsemblGeneIds (GRCh37): ENSG00000184634
OMIM: 300188, Gene2Phenotype
MED12 is in 23 panels

2 reviews

Elena Savva (Victorian Clinical Genetics Services)

Green List (high evidence)

- There's no clear geno-pheno correlation. Missense can cause any of the phenos (FGS1, LS, Ohdo and nonsyndromic ID; Charzewska 2018).
- de novo PTCs cause female-specific Hardikar syndrome, very skewed X inactivation (Li, 2020)

- Several affected female carriers have been reported: usually with milder clinical manifestation, several families showed skewed X-chr inactivation pattern in affected female carriers (Wang 2020). However some families had no correlation between clinical outcome and X-chr inactivation in the blood samples (Charzewska 2018, Prontera 2016).
Created: 23 Mar 2021, 4:42 a.m. | Last Modified: 23 Mar 2021, 4:42 a.m.
Panel Version: 0.6863

Mode of inheritance
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)

Phenotypes
Ohdo syndrome, X-linked MIM#300895; Lujan-Fryns syndrome MIM#309520; Opitz-Kaveggia syndrome MIM#305450

Publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Green List (high evidence)

Included here due to association with aortic aneurysm.
Created: 15 Aug 2020, 6:36 a.m. | Last Modified: 15 Aug 2020, 6:36 a.m.
Panel Version: 0.110

Mode of inheritance
X-LINKED: hemizygous mutation in males, biallelic mutations in females

Phenotypes
Lujan-Fryns syndrome, MIM# 309520

History Filter Activity

15 Aug 2020, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: med12 has been classified as Green List (High Evidence).

15 Aug 2020, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: MED12 were changed from to Lujan-Fryns syndrome, MIM# 309520

15 Aug 2020, Gel status: 3

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Mode of inheritance for gene: MED12 was changed from Unknown to X-LINKED: hemizygous mutation in males, biallelic mutations in females

17 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: MED12 was added gene: MED12 was added to Bleeding Disorders_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: MED12 was set to Unknown